First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
CRNX holding history
Crinetics Pharmaceuticals, Inc. in every 13F filed by First Light Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,360,866
- Value
- $50.9M
- % of portfolio
- 3.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,360,866 | $50.9M | 3.1% | +271,196+24.9% | Added | Holders |
| Q1 2026 | 1,089,670 | $39.6M | 3.5% | −104,593−8.8% | Reduced | Holders |
| Q4 2025 | 1,194,263 | $55.6M | 4.3% | +252,747+26.8% | Added | Holders |
| Q3 2025 | 941,516 | $39.2M | 3.7% | +77,380+9.0% | Added | Holders |
| Q2 2025 | 864,136 | $24.9M | 3.2% | +8,717+1.0% | Added | Holders |
| Q1 2025 | 855,419 | $28.7M | 3.3% | −30,034−3.4% | Reduced | Holders |
| Q4 2024 | 885,453 | $45.3M | 4.3% | −58,158−6.2% | Reduced | Holders |
| Q3 2024 | 943,611 | $48.2M | 4.0% | −256,897−21.4% | Reduced | Holders |
| Q2 2024 | 1,200,508 | $53.8M | 4.7% | −489,669−29.0% | Reduced | Holders |
| Q1 2024 | 1,690,177 | $79.1M | 6.1% | −297,595−15.0% | Reduced | Holders |
| Q4 2023 | 1,987,772 | $70.7M | 5.7% | +404,443+25.5% | Added | Holders |
| Q3 2023 | 1,583,329 | $47.1M | 4.5% | +26,107+1.7% | Added | Holders |
| Q2 2023 | 1,557,222 | $28.1M | 2.2% | −61,903−3.8% | Reduced | Holders |
| Q1 2023 | 1,619,125 | $26.0M | 2.3% | +289,812+21.8% | Added | Holders |
| Q4 2022 | 1,329,313 | $24.3M | 2.3% | −17,339−1.3% | Reduced | Holders |
| Q3 2022 | 1,346,652 | $26.4M | 2.7% | +106,043+8.5% | Added | Holders |
| Q2 2022 | 1,240,609 | $23.1M | 2.7% | +657,842+112.9% | Added | Holders |
| Q1 2022 | 582,767 | $12.8M | 1.1% | +309,971+113.6% | Added | Holders |
| Q4 2021 | 272,796 | $7.75M | 0.6% | +272,796 | New | Holders |